Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep;66(5):375-85.
doi: 10.3322/caac.21355. Epub 2016 Jul 19.

Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement

Debbie Saslow  1 , Kimberly S Andrews  2 , Deana Manassaram-Baptiste  2 , Lacey Loomer  3 , Kristina E Lam  4 , Marcie Fisher-Borne  5 , Robert A Smith  6 , Elizabeth T H Fontham  7 ; American Cancer Society Guideline Development Group
Affiliations
Review

Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement

Debbie Saslow et al. CA Cancer J Clin. 2016 Sep.

Abstract

Answer questions and earn CME/CNE The American Cancer Society (ACS) reviewed and updated its guideline on human papillomavirus (HPV) vaccination based on a methodologic and content review of the Advisory Committee on Immunization Practices (ACIP) HPV vaccination recommendations. A literature review was performed to supplement the evidence considered by the ACIP and to address new vaccine formulations and recommendations as well as new data on population outcomes since publication of the 2007 ACS guideline. The ACS Guideline Development Group determined that the evidence supports ACS endorsement of the ACIP recommendations, with one qualifying statement related to late vaccination. The ACS recommends vaccination of all children at ages 11 and 12 years to protect against HPV infections that lead to several cancers and precancers. Late vaccination for those not vaccinated at the recommended ages should be completed as soon as possible, and individuals should be informed that vaccination may not be effective at older ages. CA Cancer J Clin 2016;66:375-385. © 2016 American Cancer Society.

Keywords: Advisory Committee on Immunization Practices; American Cancer Society; cancer prevention; guideline; human papillomavirus (HPV); vaccine.

PubMed Disclaimer

Conflict of interest statement

DISCLOSURES: The American Cancer Society (ACS) supported the development of the guideline through the use of general funds. Outside the submitted work, the ACS is the recipient of 2 cooperative agreements from the Centers for Disease Control and Prevention (CDC), Prevention and Public Health Fund, that seek to increase human papillomavirus (HPV) vaccination of girls and boys ages 11 to 12 years within the United States. Debbie Saslow reports being Principal Investigator of both of those cooperative agreements, and Marcie Fisher-Borne reports being co-Principal Investigator and receiving salary support through one of those cooperative agreements. All remaining authors report no conflicts of interest.

References

    1. Saraiya M, Unger ER, Thompson TD, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015:107–118. - PMC - PubMed
    1. Viens LJ, Henley SJ, Watson M, et al. Human papillomavirus-associated cancers—United States, 2008–2012. MMWR Weekly. 2016;65:661–666. - PubMed
    1. Jemal A, Simard EP, Dorell C, et al. Annual Report to the Nation on the Status of Cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105:175–201. - PMC - PubMed
    1. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2007;56:1–24. - PubMed
    1. Centers for Disease Control and Prevention (CDC) FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep. 2010;59:630–632. - PubMed

Publication types

MeSH terms

Substances